Preprint Interesting Images Version 1 Preserved in Portico This version is not peer-reviewed

TAFRO Syndrome on 18F-FDG-PET/CT: An Appealing Diagnostic Tool

Version 1 : Received: 22 April 2024 / Approved: 23 April 2024 / Online: 23 April 2024 (11:58:18 CEST)

How to cite: Jaafari, A.; Taheri, N.; Mansour, S.; El Bouhali, S.; Attou, R. TAFRO Syndrome on 18F-FDG-PET/CT: An Appealing Diagnostic Tool. Preprints 2024, 2024041483. https://doi.org/10.20944/preprints202404.1483.v1 Jaafari, A.; Taheri, N.; Mansour, S.; El Bouhali, S.; Attou, R. TAFRO Syndrome on 18F-FDG-PET/CT: An Appealing Diagnostic Tool. Preprints 2024, 2024041483. https://doi.org/10.20944/preprints202404.1483.v1

Abstract

TAFRO syndrome (TS) is a rare variant of idiopathic multicentric Castleman's disease (iMCD) characterized by a confluence of symptoms: thrombocytopenia (T), anasarca (A), fever (F), reticulin myelofibrosis (R), and organomegaly (O). First described in Japan in 2010, the pathogenesis of the disease remains unclear. Due to its heterogeneous presentation and potential life-threatening delays in diagnosis, precise diagnosis is essential. According to the literature, no specific imaging modality has been recommended for the work-up of patients with suspected TS. Here, we report a case of TS and its management using 18F-FDG-PET/CT imaging as an attractive complementary diagnostic tool.

Keywords

TAFRO syndrome; multicentric Castleman disease; iMCD; 18F-FDG-PET/CT

Subject

Medicine and Pharmacology, Internal Medicine

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.